MBB Public Markets I LLC Invests $317,000 in DaVita Inc. $DVA

Key Points

• MBB Public Markets I LLC acquired 2,070 shares of DaVita Inc., valued at approximately $317,000, during the first quarter.
• DaVita reported a quarterly earnings per share (EPS) of $2.95, exceeding expectations, along with a revenue of $3.38 billion for the same period.
• Several research firms have updated their ratings and price targets for DaVita's stock, with Truist Financial setting a target of $148.00, while Barclays lowered theirs from $169.00 to $160.00.

MBB Public Markets I LLC acquired a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,070 shares of the company's stock, valued at approximately $317,000.

Other large investors have also recently made changes to their positions in the company. UMB Bank n.a. lifted its stake in shares of DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after buying an additional 76 shares in the last quarter. National Pension Service lifted its stake in shares of DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after buying an additional 84 shares in the last quarter. Copia Wealth Management bought a new position in shares of DaVita in the fourth quarter valued at $30,000. Y.D. More Investments Ltd bought a new position in shares of DaVita during the first quarter valued at about $35,000. Finally, NewEdge Advisors LLC lifted its position in shares of DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company's stock valued at $78,000 after purchasing an additional 88 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares in the company, valued at $3,905,700. The trade was a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms recently weighed in on DVA. Barclays dropped their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a research report on Thursday, August 7th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Saturday. Bank of America decreased their price objective on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a report on Wednesday, September 10th. Finally, Truist Financial set a $148.00 price objective on shares of DaVita in a report on Friday, August 8th. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average target price of $158.00.

DaVita Price Performance

NYSE:DVA traded down $2.04 during mid-day trading on Monday, hitting $131.13. 170,859 shares of the stock traded hands, compared to its average volume of 845,358. The business's 50-day moving average price is $138.45 and its 200 day moving average price is $141.47. The company has a market cap of $9.38 billion, a PE ratio of 12.90, a price-to-earnings-growth ratio of 0.95 and a beta of 1.13. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. The company had revenue of $3.38 billion during the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. DaVita's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.